• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling

tetano

Editor, Senior Moderator
Elife


. 2025 Sep 23:13:RP100248.
doi: 10.7554/eLife.100248. SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling

Fansen Meng[SUP] 1 [/SUP], Jong Hwan Kim[SUP] 2 [/SUP], Chang-Ru Tsai[SUP] 3 [/SUP], Jeffrey D Steimle[SUP] 3 [/SUP], Jun Wang[SUP] 2 [/SUP], Yufeng Shi[SUP] 2 [/SUP], Rich G Li[SUP] 1 [/SUP], Bing Xie[SUP] 3 [/SUP], Vaibhav Deshmukh[SUP] 3 [/SUP], Shijie Liu[SUP] 4 5 [/SUP], Xiao Li[SUP] 1 [/SUP], James F Martin[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

The Hippo pathway controls organ development, homeostasis, and regeneration primarily by modulating YAP/TEAD-mediated gene expression. Although emerging studies report Hippo-YAP dysfunction after viral infection, it is largely unknown in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we analyzed RNA sequencing data from human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and SARS-CoV-2-infected human lung samples, and observed a decrease in YAP target gene expression. In screening SARS-CoV-2 nonstructural proteins, we found that nonstructural protein 13 (NSP13), a conserved coronavirus helicase, inhibits YAP transcriptional activity independent of the upstream Hippo kinases LATS1/2. Consistently, introducing NSP13 into mouse cardiomyocytes suppresses an active form of YAP (YAP5SA) in vivo. Subsequent investigations on NSP13 mutants revealed that NSP13 helicase activity, including DNA binding and unwinding, is crucial for suppressing YAP transactivation in HEK293T cells. Mechanistically, TEAD4 serves as a platform to recruit NSP13 and YAP. NSP13 likely inactivates the YAP/TEAD4 transcription complex by remodeling chromatin to recruit proteins, such as transcription termination factor 2 (TTF2), to bind the YAP/TEAD/NSP13 complex. These findings reveal a novel YAP/TEAD regulatory mechanism and uncover molecular insights into Hippo-YAP regulation after SARS-CoV-2 infection in humans.

Keywords: Hela; Hippo pathway; NSP13; SARS-CoV2; TEAD; YAP; cardiomyocytes; cell biology; mouse; viruses.

 
Back
Top